Research Article
MicroRNA Expression Signature in Human Calcific Aortic Valve Disease
Table 3
The pathways affected by upregulation of specific microRNAs in CAVD.
| KEGG pathway | value | Genes | miRNAs |
| p53 signaling pathway | | 11 | 2 | HIF-1 signaling pathway | 0.00023 | 10 | 2 | Valine, leucine, and isoleucine biosynthesis | 0.00227 | 1 | 1 | ErbB signaling pathway | 0.003959 | 5 | 1 | Cell cycle | 0.003959 | 10 | 2 | mTOR signaling pathway | 0.004909 | 6 | 1 | MAPK signaling pathway | 0.005193 | 15 | 2 | PI3K-Akt signaling pathway | 0.005193 | 17 | 2 | Wnt signaling pathway | 0.008586 | 10 | 1 | Synthesis and degradation of ketone bodies | 0.009366 | 2 | 1 | TGF-beta signaling pathway | 0.021216 | 7 | 1 | Basal transcription factors | 0.029417 | 4 | 1 | Glycerophospholipid metabolism | 0.030271 | 8 | 1 | Hypertrophic cardiomyopathy (HCM) | 0.030271 | 6 | 1 | Focal adhesion | 0.030271 | 11 | 2 | Circadian rhythm | 0.030848 | 3 | 1 | Mismatch repair | 0.034518 | 2 | 1 | Lysine degradation | 0.038471 | 4 | 1 | Butanoate metabolism | 0.038615 | 3 | 1 |
|
|
Specific types of cancers and infections were not included.
|